Newer antidepressants and panic disorder: a meta-analysis.

@article{Andrisano2013NewerAA,
  title={Newer antidepressants and panic disorder: a meta-analysis.},
  author={Costanza Andrisano and Alberto Chiesa and Alessandro Serretti},
  journal={International clinical psychopharmacology},
  year={2013},
  volume={28 1},
  pages={
          33-45
        }
}
Selective serotonin reuptake inhibitors and venlafaxine are currently considered as first-line agents for patients with panic disorder (PD). However, a systematic comparison of newer antidepressants for the treatment of PD is lacking thus far. Eligible studies focusing on PD patients treated with newer antidepressants were entered in the Cochrane Collaboration Review Manager. Our primary outcome measure was the mean change in panic symptoms from the baseline to the endpoint in patients treated… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient

  • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2019
VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED